Immune alterations in untreated and treated myelodysplastic syndrome.

@article{Mewawalla2011ImmuneAI,
  title={Immune alterations in untreated and treated myelodysplastic syndrome.},
  author={Prerna Mewawalla and Constantin A. Dasanu},
  journal={Expert opinion on drug safety},
  year={2011},
  volume={10 3},
  pages={351-61}
}
INTRODUCTION Current literature suggests a variety of immune abnormalities are present in myelodysplastic syndrome (MDS) patients. However, they have not been comprehensively characterized or systematized to date. As a result, their clinical implications remain largely unknown. In addition, an increased incidence of various autoimmune conditions has been documented in MDS patients. AREAS COVERED The authors offer a comprehensive review of the existing literature on immune mechanisms involved… CONTINUE READING
3 Citations
96 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 96 references

Cyclosporine A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic Immune alterations in untreated and treated myelodysplastic syndrome

  • A Jonasova, R Neuwirtova, J Cermak
  • Expert Opin. Drug Saf
  • 2011
1 Excerpt

Similar Papers

Loading similar papers…